| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.49B | 9.57B | 9.99B | 10.11B | 9.49B | 8.92B |
| Gross Profit | 3.27B | 3.31B | 2.19B | 4.34B | 4.03B | 3.88B |
| EBITDA | 1.79B | 2.06B | 2.64B | 2.68B | 2.52B | 2.47B |
| Net Income | 916.00M | 910.00M | 1.23B | 1.19B | 1.08B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 16.93B | 17.45B | 17.36B | 18.18B | 18.38B | 18.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.71B | 1.61B | 1.73B | 1.99B | 1.79B | 1.52B |
| Total Debt | 3.75B | 4.23B | 4.27B | 4.97B | 5.94B | 6.40B |
| Total Liabilities | 6.08B | 6.63B | 6.50B | 7.71B | 8.21B | 8.53B |
| Stockholders Equity | 10.75B | 10.72B | 10.76B | 10.37B | 10.10B | 9.75B |
Cash Flow | ||||||
| Free Cash Flow | 1.59B | 1.16B | 1.57B | 2.40B | 1.86B | 1.75B |
| Operating Cash Flow | 1.98B | 1.56B | 1.88B | 2.72B | 2.39B | 2.54B |
| Investing Cash Flow | -451.00M | -297.00M | -157.00M | -667.00M | -879.00M | -773.00M |
| Financing Cash Flow | -1.23B | -1.32B | -1.90B | -2.20B | -1.60B | -1.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$570.80B | 13.70 | 7.19% | 5.40% | 0.53% | 5.28% | |
67 Neutral | HK$1.75T | 11.87 | 10.31% | 6.00% | 1.49% | 3.06% | |
67 Neutral | HK$93.19B | 6.78 | 14.46% | 2.86% | 2.33% | 2.41% | |
65 Neutral | HK$10.14B | 9.94 | 8.45% | 7.46% | -0.62% | -5.10% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
50 Neutral | HK$11.59B | 18.62 | 8.82% | 5.45% | 4.48% | 1820.51% | |
49 Neutral | HK$45.60B | -1,547.01 | -2.39% | 1.68% | 4.26% | 36.68% |